The FDA-approved Inluriyo, an oral estrogen receptor antagonist from Eli Lilly, has shown to achieve significant improvement in progression-free survival for breast cancer.

You’ve probably heard rumors that testosterone makes men gain weight. The truth? It’s usually the opposite. Healthy testosterone levels actually help men maintain lean muscle, manage ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery—the ...

"When you challenge your arm muscles with resistance, you create microscopic tears in the muscle fibers," an expert told Newsweek.

This article was reviewed by Jessica Shepherd, MD. Menopause and Hair Thinning: 7 Common Questions Answered Menopause hair thinning is a common and completely natural part ...

Crinetics Pharmaceuticals gains FDA approval for PALSONIFY, targeting key unmet needs in Acromegaly. Click here to read my latest analysis on CRNX stock.

Breast cancer originates as an abnormal growth of cells within the breast tissue. Excluding skin cancer, it is the most common cancer diagnosed in women in the United States. Since ...

Shares of Crinetics Pharmaceuticals were higher in off-hours trading after the FDA approved its treatment of Acromegaly, a rare disorder that results in the body producing too much growth hormone. The ...

The U.S. Food and Drug Administration approved Crinetics Pharmaceuticals' drug to treat a rare hormonal disorder on Thursday, making it the first once-daily oral pill available for patients in the ...

Also known as androgenetic alopecia, female pattern hair loss (FPHL) will affect 40 percent of women by age 50, according to the Journal of the American Academy of Dermatology. This chronic and slow ...

An international team of scientists has unraveled the mysterious relationship between gravity, and the growth trajectories of plant roots.